IDH1 and central nervous system cancer: However, the mutated IDH1 R132H enzyme produced the metabolite D-2-hydroxyglutarate (2-HG), which competitively inhibited many α-KG-dependent dioxygenases, leading to histone dysregulation and abnormal angiogenesis, and ultimately inducing glioma.